ONO7475
- Product Name
- ONO7475
- CAS No.
- 1646839-59-9
- Chemical Name
- ONO7475
- Synonyms
- ONO7475;tamnorzatinib;ONO-7475 ,S8933;ONO-7475, 10 mM in DMSO;Tamnorzatinib (ONO-7475);N-(5-((6,7-Dimethoxyquinolin-4-yl)oxy)pyridin-2-yl)-2,5-dioxo-1-phenyl-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide;3-Quinolinecarboxamide, N-[5-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-pyridinyl]-1,2,5,6,7,8-hexahydro-2,5-dioxo-1-phenyl-;N-(5-((6,7-Dimethoxyquinolin-4-yl)oxy)pyridin-2-yl)-2,5-dioxo-1-phenyl-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide , Tamnorzatinib;lung,tumor,leukemia,inhibit,solid,Trk Receptor,tolerant,cancer,Mer,Tropomyosin related kinase receptor,NSCLC,TAM Receptor,EGFR,ONO 7475,Tyro3,advanced,ONO7475,mutunt,Inhibitor,Axl,TKI,acute,ONO-7475,metastatic
- CBNumber
- CB65867703
- Molecular Formula
- C32H26N4O6
- Formula Weight
- 562.57
- MOL File
- 1646839-59-9.mol
ONO7475 Property
- Boiling point:
- 804.0±65.0 °C(Predicted)
- Density
- 1.43±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMF: 30 mg/ml,DMSO: 30 mg/ml,DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml
- form
- A crystalline solid
- pka
- 8.50±0.20(Predicted)
- color
- Light yellow to yellow
N-Bromosuccinimide Price
- Product number
- CS-0083699
- Product name
- ONO-7475
- Purity
- 99.38%
- Packaging
- 5mg
- Price
- $250
- Updated
- 2021/12/16
- Product number
- CS-0083699
- Product name
- ONO-7475
- Purity
- 99.38%
- Packaging
- 10mg
- Price
- $350
- Updated
- 2021/12/16
- Product number
- CS-0083699
- Product name
- ONO-7475
- Purity
- 99.38%
- Packaging
- 50mg
- Price
- $780
- Updated
- 2021/12/16
- Product number
- 013318
- Product name
- ONO-7475
- Packaging
- 002
- Price
- $950
- Updated
- 2021/12/16
- Product number
- 013318
- Product name
- ONO-7475
- Packaging
- 003
- Price
- $1900
- Updated
- 2021/12/16
ONO7475 Chemical Properties,Usage,Production
Uses
Tamnorzatinib (ONO-7475) is a potent, selective, and orally active Axl/Mer inhibitor with IC50 values of 0.7 nM and 1.0 nM, respectively. Tamnorzatinib sensitizes AXL-overexpressing EGFR-mutant NSCLC cells to the EGFR-TKIs, suppresses the emergence and maintenance of tolerant cells. Tamnorzatinib combines with Osimertinib (HY-15772) provides a bright promise for the study of EGFR-mutated non-small cell lung cancer (NSCLC).
in vivo
Tamnorzatinib (oral gavage; 10 mg/kg or combines with 5 mg/kg Osimertinib; 29 days) treatment alone has little effect on the tumor growth. Besides, Osimertinib alone causes tumor regression within one week, but the tumors reappear within three weeks. The combined initial treatment causes tumor regression and the size of tumors is maintained for 4 weeks. No apparent adverse events, including weight loss are observed during these treatments[1].
| Animal Model: | Mouse CDX model using high-AXL-expressing PC-9KGR cells (exon 19 deletion and the exon21-T790M mutation in EGFR)[1] |
| Dosage: | 10 mg/kg; once daily; 19 days |
| Administration: | oral gavage |
| Result: | Had little effects alone, but combined treatments significantly decreased tumor volume without reappear. |
IC 50
TrkA; Axl; Tyro3; Mer
References
[1] Okura N, et al. ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in?EGFR-Mutated Non-Small Lung Cancer.Clin Cancer Res.?2020 Jan 17. DOI:10.1158/1078-0432.CCR-19-2321
[2] Ruvolo PP, et al. Anexelekto/MER tyrosine kinase?inhibitor?ONO-7475?arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms.Haematologica.?2017 Dec;102(12):2048-2057. DOI:10.3324/haematol.2017.168856
ONO7475 Preparation Products And Raw materials
Raw materials
Preparation Products
ONO7475 Suppliers
- Tel
- 028-81700200 18116577057
- Fax
- 028-81705658
- 3003855609@qq.com
- Country
- China
- ProdList
- 7778
- Advantage
- 56
- Tel
- 021-52996696,15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4762
- Advantage
- 55
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 0-2022843681 15618226720
- Fax
- +86-21-51601218
- chaolaichem@foxmail.com
- Country
- China
- ProdList
- 12476
- Advantage
- 58
- Tel
- 028-85157043 15882256948
- 676046971@qq.com
- Country
- China
- ProdList
- 4180
- Advantage
- 58
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- +1-708-310-1919 +1-13798911105
- Fax
- 708-557-7486
- sales@invivochem.cn
- Country
- United States
- ProdList
- 6391
- Advantage
- 58
- Tel
- 86-571-88216897,88216896 13588875226
- Fax
- 86-571-88216895
- sales@hzclap.com
- Country
- CHINA
- ProdList
- 6312
- Advantage
- 58